Skip to main content

PATIENT TEXT INFORMATION – WEIGHT LOSS SERVICE

Package leaflet: Information for the patient

https://www.medicines.org.uk/emc/files/pil.15481.pdf

Mounjaro kwik pen leaflet

https://info.mkthealthcare.com/uk-mounjaro-obesity?redirect-referrer=https%3A%2F%2Fuk.lilly.com%2Fdiabetes%2Fpatient%2Fobesity

Instructions for Use

https://www.medicines.org.uk/emc/files/usermanual.15484.pdf

Compulsory Behaviour support (BSOP) Information

GLP 1 | What it is, what it does (Part 1)

https://www.youtube.com/watch?v=9i0ke09XyuA

GLP 1 | Starting GLP 1 (Part 2)

https://www.youtube.com/watch?v=Wtg6Mv5k7v8

GLP 1 | Getting the most of your GLP 1 (Part 3)

https://www.youtube.com/watch?v=RAF5miLcMiw

GLP-1 Treatment Guidance for Diet

https://g-care.glos.nhs.uk/uploads/patient_information/GLP-1%20for%20T2%20diabetes%20Dietary%20Guidelines%20May%202025.pdf

HRT CONSIDERATIONS

If you are taking HRT it is suggested, you speak to our pharmacist or GP to discuss possible changes to your regime whilst on weight loss injections.

CONTRACEPTIONS CONSIDERATIONS

Please also be aware, that all women on weight loss injections should also be on contraception. It should also be noted those on the injections should switch to a non- oral method, or add a barrier method, for four weeks after initiation and four weeks after each dose increase.

OTHER POTENTIAL SIDE EFFECTS AND WARNING

Pancreatitis (inflammation of the pancreas) is a possible side effect with GLP-1 receptor agonists and dual GLP-1/ GIP receptor agonists. In rare reports this can have serious or fatal outcomes

Seek urgent medical attention if you experience severe, persistent abdominal pain, that may radiate to your back and may be accompanied by nausea and vomiting, as this may be a sign of pancreatitis

Do not restart GLP-1 receptor agonist or GLP-1/GIP receptor agonist treatment if pancreatitis is confirmed

SURGICAL CONSIDERATIONS TO INFORM PROFESSIONALS ABOUT

If you are taking a GLP-1 or dual GIP/GLP-1 receptor agonist, make sure you inform your healthcare team including the anaesthetist about this prior to your surgical procedure

This medicine slows the emptying of your stomach, increasing the risk that stomach contents (e.g. food and drink) could enter into your airways and lungs during surgery or procedures whilst you are under general anaesthesia or deep sedation. This means that a modification to the pre-procedure instruction and anaesthetic technique may be required

Take your prescribed medicine(s) as usual and do not stop your treatment without first discussing this with your doctor

PREGNANCY CONSIDERATIONS

GLP-1 receptor agonists

DIETARY CONSIDERATIONS

https://g-care.glos.nhs.uk/education-training/weight-management/tirzepatide-nutritional-considerations

Page published: 28 August 2026
Last updated: 14 September 2026